Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement

NCT01684631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2016-09-26

No results posted yet for this study

Summary

The objective is to evaluate the implant survival rate for patients implanted with a PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the treatment of a severe hip disease and true femoral cervical fracture.

Conditions

  • Arthropathy of Hip

Interventions

DEVICE

Total Hip arthroplasty

Sponsors & Collaborators

  • DePuy International

    lead INDUSTRY

Principal Investigators

  • Jean-Marie Toupin, MD · Clinique Saint Hilaire Rouen, France 76000

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684631 on ClinicalTrials.gov